1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,500 | 0,520 | 04.09. | |
| 0,490 | 0,525 | 04.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.08. | FibroBiologics reports 1H results | 5 | Seeking Alpha | ||
| 31.07. | FibroBiologics, Inc.: FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | 145 | GlobeNewswire (Europe) | HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development... ► Artikel lesen | |
| 31.07. | FibroBiologics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 28.07. | FibroBiologics files patent for multipotent cell generation method | 1 | Investing.com | ||
| 28.07. | FibroBiologics, Inc.: FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications | 2 | GlobeNewswire (USA) | ||
| 18.07. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.07. | RedChip Companies, Inc.: Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 423 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc. (NASDAQ:TBH) and FibroBiologics, Inc. (NASDAQ:FBLG) on the RedChip Small Stocks,... ► Artikel lesen | |
| FIBROBIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 11.07. | FibroBiologics, Inc.: FibroBiologics to Present at the Advanced Wound Care Summit USA | 2 | GlobeNewswire (USA) | ||
| 07.07. | FibroBiologics, Inc.: FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10 | 1 | GlobeNewswire (USA) | ||
| 03.07. | FibroBiologics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.07. | RedChip Companies, Inc.: Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 363 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc. (Nasdaq:FTHM) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks... ► Artikel lesen | |
| 16.06. | FibroBiologics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.06. | FibroBiologics, Inc.: FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing | 2 | GlobeNewswire (USA) | ||
| 16.06. | FibroBiologics, Inc.: FibroBiologics to Present at the BIO International Convention 2025 | 3 | GlobeNewswire (USA) | ||
| 09.06. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.06. | FibroBiologics Appoints Jason Davis As CFO | 2 | RTTNews | ||
| 09.06. | FibroBiologics announces CFO appointment | 1 | Seeking Alpha | ||
| 09.06. | FibroBiologics appoints new CFO amid clinical trials | 1 | Investing.com | ||
| 09.06. | Fibrobiologics, Inc.: FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer | 241 | GlobeNewswire (Europe) | HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development... ► Artikel lesen | |
| 16.05. | Fibrobiologics, Inc.: FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 89,10 | +3,42 % | BioNtech Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| CUREVAC | 4,592 | 0,00 % | CureVac Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| MODERNA | 20,490 | -0,12 % | Moderna, Inc.: Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism | CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at... ► Artikel lesen | |
| PAION | 0,013 | -50,00 % | Paion Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| NOVAVAX | 6,685 | +5,38 % | Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment | ||
| NANOREPRO | 1,850 | -0,80 % | HV-Termine: Hauptversammlungen u.a. bei Baywa, Circus, Daldrup, Laiqon, NanoRepro, Pyramid, Umweltbank | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| 4SC | 0,582 | -7,03 % | PTA-News: 4SC AG: 4SC veröffentlicht Halbjahresbericht 2025 | DJ PTA-News: 4SC AG: 4SC veröffentlicht Halbjahresbericht 2025
Unternehmensmitteilung für den Kapitalmarkt
4SC AG: 4SC veröffentlicht Halbjahresbericht 2025
Planegg-Martinsried (pta000/08.08.2025/07:30... ► Artikel lesen | |
| VIVOSIM LABS | 1,220 | -100,00 % | VivoSim Labs, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| INOVIO PHARMACEUTICALS | 2,300 | -0,86 % | INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug | ||
| INFLARX | 1,323 | -10,06 % | H.C. Wainwright assumes coverage on Inflarx stock with Buy rating | ||
| SCORPIUS | 0,070 | 0,00 % | Scorpius Holdings, Inc. - 8-K, Current Report | ||
| DEFENCE THERAPEUTICS | 0,468 | +4,00 % | Defence Therapeutics Inc.: Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth | Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 7,032 | -1,18 % | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted... ► Artikel lesen | |
| DYNAVAX | 8,552 | -1,63 % | Dynavax Technologies: Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile | At all doses and formulations evaluated in Part 1 of the trial, Z-1018 was well-tolerated and demonstrated a favorable tolerability profile, including lower solicited... ► Artikel lesen | |
| IBIO | 0,670 | -8,22 % | XFRA DIVERSE ISINS: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
FIBROBIOLOGICS INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,515 Euro und damit -0,96 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIBROBIOLOGICS INC finden Sie auf Wallstreet Online.